Clinical Trial Update: Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of BZ371A for female sexual arousal disorder; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Arousal Disorder
• Female Sexual Dysfunction

Drugs mentioned

• BZ371A

Snippet

Sponsor: Biozeus Biopharmaceutical S.A. | Conditions: Female Sexual Arousal Disorder, Female Sexual Dysfunction (FSD) | Phase 2 | Status: NOT_YET_RECRUITING